These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38554338)

  • 1. Protective effects of Panax Ginseng against 131I-induced genotoxicity in patients with differentiated thyroid cancer.
    Omrani V; Fardid R; Alavi M; Haddadi G; Takhshid MA
    J Cancer Res Ther; 2024 Jan; 20(1):304-310. PubMed ID: 38554338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of protective and mitigating effects of vitamin C against side effects induced by radioiodine therapy.
    Jafari E; Alavi M; Zal F
    Radiat Environ Biophys; 2018 Aug; 57(3):233-240. PubMed ID: 29860661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine: predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapies.
    Hartung-Knemeyer V; Nagarajah J; Jentzen W; Ruhlmann M; Freudenberg LS; Stahl AR; Bockisch A; Rosenbaum-Krumme SJ
    Ann Nucl Med; 2012 Nov; 26(9):723-9. PubMed ID: 22802008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study.
    Han N; Lu C; Li J; Wang C; Zhao Z; Zhang Y; Liu X; Si Z; Wang G; Wang Z; Li F; Wang X
    Front Endocrinol (Lausanne); 2023; 14():1222470. PubMed ID: 37810895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Immune Function Changes Before and After the First Radioactive Iodine Therapy After Total Resection of Differentiated Thyroid Carcinoma.
    Shi ZY; Zhang SX; Fan D; Li CH; Cheng ZH; Xue Y; Wu LX; Lu KY; Yang SY; Cheng Y; Wu ZF; Gao C; Li XF; Liu HY; Li SJ
    Front Immunol; 2022; 13():901263. PubMed ID: 35844520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with iodine-131.
    Dardano A; Ballardin M; Caraccio N; Boni G; Traino C; Mariani G; Ferdeghini M; Barale R; Monzani F
    Thyroid; 2012 Mar; 22(3):318-24. PubMed ID: 22181338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
    Silva-Vieira M; Carrilho Vaz S; Esteves S; Ferreira TC; Limbert E; Salgado L; Leite V
    Thyroid; 2017 Aug; 27(8):1068-1076. PubMed ID: 28614983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment.
    Sohn SY; Choi JH; Kim NK; Joung JY; Cho YY; Park SM; Kim TH; Jin SM; Bae JC; Lee SY; Chung JH; Kim SW
    Thyroid; 2014 May; 24(5):872-7. PubMed ID: 24295076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of body iodine pool assessment methods before radioiodine therapy.
    Genc M; Yildirim A; Yildirim N
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(2):107-112. PubMed ID: 38331249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Influencing the Success of the First Radioiodine Therapy for Differentiated Thyroid Carcinoma.
    Claimon A; Pusuwan P; Khiewvan B
    J Med Assoc Thai; 2017 Feb; 100(2):207-18. PubMed ID: 29916638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated With Radioactive Iodine Therapy.
    Bojarsky M; Baran JA; Halada S; Isaza A; Zhuang H; States L; Grant FD; Robbins S; Sisko L; Ricarte-Filho JC; Kazahaya K; Adzick NS; Mostoufi-Moab S; Bauer AJ
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3338-3344. PubMed ID: 37265226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of apitherapy against salivary gland disorder after radioactive iodine therapy for differentiated thyroid cancer.
    Nomura K; Nakayama M; Okizaki A
    Ann Nucl Med; 2023 Aug; 37(8):462-469. PubMed ID: 37149836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To Use or Not to Use 131I in Thyroid Cancer.
    Metter D; Phillips WT; Walker RC; Blumhardt R
    Clin Nucl Med; 2018 Sep; 43(9):670-671. PubMed ID: 30080184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients.
    Campennì A; Ruggeri RM; Siracusa M; Comis AD; Romano D; Vento A; Lanzafame H; Capoccetti F; Alibrandi A; Baldari S; Giovanella L
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2466-2475. PubMed ID: 33416957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of Panax ginseng against serum biochemical changes and apoptosis in kidney of rats treated with gentamicin sulphate.
    Kalkan Y; Kapakin KA; Kara A; Atabay T; Karadeniz A; Simsek N; Karakus E; Can I; Yildirim S; Ozkanlar S; Sengul E
    J Mol Histol; 2012 Oct; 43(5):603-13. PubMed ID: 22487736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of Stimulated Thyroglobulin and Antithyroglobulin Antibody Predicts the Efficacy and Prognosis of
    Pan M; Li Z; Jia M; Lu X
    Front Endocrinol (Lausanne); 2022; 13():857057. PubMed ID: 35464061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined BRAF
    Campennì A; Ruggeri RM; Siracusa M; Pignata SA; Di Mauro F; Vento A; Trimarchi F; Baldari S
    J Endocrinol Invest; 2018 Nov; 41(11):1283-1288. PubMed ID: 29549631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea.
    Seo GH; Cho YY; Chung JH; Kim SW
    Thyroid; 2015 Aug; 25(8):927-34. PubMed ID: 26133388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avidity and Outcomes of Radioiodine Therapy for Distant Metastasis of Distinct Types of Differentiated Thyroid Cancer.
    Simões-Pereira J; Mourinho N; Ferreira TC; Limbert E; Cavaco BM; Leite V
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e3911-e3922. PubMed ID: 34134139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of timing of radioimmunotherapy after granulocyte colony-stimulating factor administration for peripheral blood stem cell harvest.
    Juweid ME; Blumenthal RD; Lew W; Hajjar G; Rubin AD; Goldenberg DM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3337s-3342s. PubMed ID: 10541383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.